About Indonesia Energy Corp. Ltd. Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between ...
Medicus Pharma (NASDAQ:MDCX) earlier this week outlined further progress in its Skinject program following the release of Phase 2 topline data, alongside independent validation from a leading ...
Artemis 2's Orion capsule is scheduled to conduct a crucial engine burn this evening (April 2) that will send it to the moon. When you purchase through links on our site, we may earn an affiliate ...
PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs ...
A woman is trapped in a limited location where a group of people intend to kill her, sacrificing her to Satan to enrich their own power. Unwilling to surrender, she fights her way through various ...
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's (NOVOb.CO), opens new tab insulin injection, Awiqli, to control blood sugar levels in adults living with type 2 ...
200µg Cohort at Day 57 Dataset suggests majority of treated Lesions may Avoid Surgery as Company targets larger unmet medical need in Non-melanoma Skin Cancer PHILADELPHIA, March 26, 2026 (GLOBE ...
Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention. PHILADELPHIA, PA / ACCESS ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results